Therapy for children with invasive pneumococcal infections

Pediatrics

Volumn 99, Issue 2, 1997, Pages 289-299

  Halsey, N A ^a   Chesney, P J ^a   Gerber, M A ^a   Gromisch, D S ^a   Kohl, S ^a   Marcy, S M ^a   Marks, M I ^a   Murray, D L ^a   Overall J C , Jr ^a   Pickering, L K ^a   Whitley, R J ^a   Yogev, R ^a   Peter, G ^a   Hall, C B ^a   Breiman, R ^a   Hadler, S C ^a   Hardegree, M C ^a   Jacobs, R F ^a   MacDonald, N E ^a   Orenstein, W A ^a   Rabinovich, N R ^a   Schwartz, B ^a   McCracken G H , Jr ^a   Kaplan, S L ^a   Jorgensen, J H ^a   more..

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFOTAXIME; CEFTRIAXONE; CHLORAMPHENICOL; CLINDAMYCIN; COTRIMOXAZOLE; DEXAMETHASONE; ERYTHROMYCIN; IMIPENEM; MEROPENEM; PENICILLIN G; RIFAMPICIN; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; BACTERIAL MENINGITIS; CHILD; DRUG EFFICACY; DRUG PENETRATION; HUMAN; IMMUNE DEFICIENCY; IMMUNOCOMPETENCE; INTRAVENOUS DRUG ADMINISTRATION; MINIMUM INHIBITORY CONCENTRATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; TREATMENT FAILURE;

ANTI-BACTERIAL AGENTS; CHILD; DIAGNOSIS, DIFFERENTIAL; DRUG RESISTANCE, MICROBIAL; DRUG THERAPY, COMBINATION; HUMANS; MENINGITIS, BACTERIAL; MENINGITIS, VIRAL; MICROBIAL SENSITIVITY TESTS; PNEUMOCOCCAL INFECTIONS; RIFAMPIN; VANCOMYCIN;

EID: 0030993807     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.99.2.289     Document Type: Review

References (82)

1. Spratt B. Resistance to antibiotics mediated by target alterations. Science. 1994;264:388-393
2. Doern GV, Brueggemann A, Holley HP Jr, et al. Antimicrobial resistance of Streptococcus pneumoniae recovered from outpatients in the United States during the winter months of 1994 to 1995: results of a 30 center national surveillance study. Antimicrob Agents Chemother. 1996; 40:1208-1213
3. Barry AL, Pfaller MA, Fuchs PC, Packer RR. In vitro activities of 12 orally administered antimicrobial agents against four species of bacterial respiratory pathogens from US medical centers in 1992 and 1993. Antimicrob Agents Chemother. 1994;38:2419-2425
4. Thornsberry C, Brown SD, Yee C, et al. Increasing penicillin resistance in Streptococcus pneumoniae in the US: effect on susceptibility to oral cephalosporins. Infect Med. 1993;93(suppl):15-24
5. Jorgensen JH, Doern GV, Maher LA, Howell AW, Redding JS. Antimicrobial resistance among respiratory isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae in the United States. Antimicrob Agents Chemother. 1990;34:2075-2080
6. Spika JS, Facklam RR, Plikaytis BD, Oxtoby MJ, The Pneumococcal Surveillance Working Group. Antimicrobial resistance of Streptococcus pneumoniae in the United States, 1979-1987. J Infect Dis. 1991;163: 1273-1278
7. Kaplan SL, U.S. Pediatric Multicenter Pneumococcal Surveillance Group. Surveillance of pneumococcal infections in children. In: Program and Abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy (New Orleans, LA). Washington DC: American Society for Microbiology; 1996:252 #K16
8. Hofmann J, Cetron MS, Parley MM, et al. The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta. N Engl J Med. 1995;333: 481-486
9. Friedland IR, Shelton S, Paris M, et al. Dilemmas in diagnosis and management of cephalosporin-resistant Streptococcus pneumoniae meningitis. Pediatr Infect Dis J. 1993;12:196-200
10. McCracken GH Jr. Emergence of resistant Streptococcus pneumoniae: a problem in pediatrics. Pediatr Infect Dis J. 1995;14:424-428
11. Paris MM, Ramilo O, McCracken GH Jr. Management of meningitis caused by penicillin-resistant Streptococcus pneumoniae. Antimicrob Agents Chemother. 1995;39:2171-2175
12. Paris MM, Medley F, Pastor P, Murphy TV. Population-based surveillance for penicillin-and cephalosporin-resistant Streptococcus pneumoniae in Dallas County. In: Program and Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy (San Francisco, CA). Washington, DC: American Society for Microbiology; 1995:89
13. Orenstein JB. Invasive pneumococcal injection in a community hospital, 1993 to 1995. Arch Pediatr Adolesc Med. 1996;150:809-814
14. Mason EO, Kaplan SL, Lamberth LB, Tillman J. Increased rate of isolation of penicillin-resistant Streptococcus pneumoniae in a children's hospital and in vitro susceptibilities to antibiotics of potential therapeutic use. Antimicrob Agents Chemother. 1992;36:1703-1707
15. Tan TQ, Mason EO, Kaplan SL. Systemic infections due to a Streptococcus pneumoniae relatively resistant to penicillin in a children's hospital: clinical management and outcome. Pediatrics. 1992;90:928-933
16. Stanek RJ, Mufson MA. Emergence of penicillin-resistant invasive pneumococci in a single American community. Am J Med Sci. 1995;310: 150-155
17. Rathore MH, Jenkins SG. Epidemiology of resistant (R) S. pneumoniae (Sp): a six year prospective study. Pediatr Res. 1994;35:120A
18. Thompson JW, Lewno MJ, Schutze GE. Antibiotic-resistant pneumococcal disease at Arkansas Children's Hospital, 1990 to 1993. Pediatr Infect Dis J. 1994;13:408-409
19. Leggiadro RJ, Davis Y, Hill B, Facklam RR, Tenover FC. Increasing rates of invasive drug-resistant Streptococcus pneumoniae (DRSP) in Memphis. In: Abstracts of the Infectious Disease Society of America 33rd Annual Meeting (San Francisco, CA). September 16-18, 1995:72
20. Quinonez JM, Mancao MY. Retrospective review of Streptococcus pneumoniae bacteremia at the University of South Alabama Children's and Women's Hospital 1992-1994. J Invest Med. 1996;44:11A
21. Hagland LA, Istre GR, Pickett DA, Welch DF, Fine DP, The Pneumococcus Study Group. Invasive pneumococcal disease in central Oklahoma: emergence of high-level penicillin resistance and multiple antibiotic resistance. J Infect Dis. 1993;168:1532-1536
22. Zangwill KM, Vadheim CM, Eriksen E, et al. Epidemiology of invasive pneumococcal disease in the Southern California Kaiser-Permanente patient population (SCKP). Pediatr Res. 1994;35:123A
23. Welby PL, Keller DS, Cromien JL, Tebas P, Storch GA. Resistance to penicillin and non-beta-lactam antibiotics of Streptococcus pneumoniae at a children's hospital. Pediatr Infect Dis J. 1994;13:281-287
24. Fairchok, MP, Ashton WS, Fischer GW. Carriage of penicillin-resistant pneumococci in a military population in Washington, DC: risk factors and correlation with clinical isolates. Clin Infect Dis. 1996;22:966-972
25. Pikis A, Akram S, Donkersloot JA, Campos JM, Rodriguez WJ. Penicillin-resistant pneumococci from pediatric patients in the Washington, DC area. Arch Pediatr Adolesc Med. 1995;149:30-35
26. Klugman KP. Pneumococcal resistance to antibiotics. Clin Microbiol Rev. 1990;3:171-196
27. Coffey TJ, Dowson CG, Daniels M, et al. Horizontal transfer of multiple penicillin-binding protein genes, and capsular biosynthetic genes, in natural population of Streptococcus pneumoniae. Mol Microbiol. 1991;5: 2255-2260
28. Bradley JS, Connor JD. Ceftriaxone failure in meningitis caused by Streptococcus pneumoniae with reduced susceptibility to beta lactam antibiotics. Pediatr Infect Dis J. 1991;10:871-873
29. Sloas MM, Barrett FF, Chesney PJ, et al. Cephalosporin treatment failure in penicillin and cephalosporin resistant Streptococcus pneumoniae meningitis. Pediatr Infect Dis J. 1992;11:662-666
30. McDougal LK, Rasheed JK, Biddle JW, Tenover FC. Identification of multiple clones of extended-spectrum cephalosporin-resistant Streptococcus pneumoniae isolates in the United States. Antimicrob Agents Chemother. 1995;39:2282-2288
31. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. In: Sixth Informational Supplement: NCCLS Document M100-S6. Villanova, PA: National Committee for Clinical Laboratory Standards; 1995;15(14)
32. Klugman K, Friedland IR, Bradley JS. Bactericidal activity against cephalosporin-resistant Streptococcus pneumoniae in cerebrospinal fluid of children with acute bacterial meningitis. Antimicrob Agents Chemother. 1995;39:1988-1992
33. Friedland IR. Comparison of the response to antimicrobial therapy of penicillin-resistant and penicillin-susceptible pneumococcal disease. Pediatr Infect Dis J. 1995;14:885-890
34. Macias EA, Mason EO Jr, Ocera HY, LaRocco MT. Comparison of E test with standard broth microdilution for determining antibiotic susceptibilities of penicillin-resistant strains of Streptococcus pneumoniae. J Clin Microbiol. 1994;32:430-432
35. Skulnick M, Small GW, Lo P, et al. Evaluation of accuracy and reproducibility of E test for susceptibility testing of Streptococcus pneumoniae to penicillin, cefotaxime, and ceftriaxone. J Clin Microbiol. 1995;33: 2334-2337
36. Nolte FS, Metchock B, Williams T, Diem L, Bressler A, Tenover FC. Detection of penicillin-resistant Streptococcus pneumoniae with commercially available broth microdilution panels. J Clin Microbiol. 1995;33: 1804-1806
37. Block SL, Harrison CJ, Hedrick JA, et al. Penicillin-resistant Streptococcus pneumoniae in acute otitis media: risk factors, susceptibility patterns and antimicrobial management. Pediatr Infect Dis J. 1995;14:751-759
38. Centers for Disease Control. Summary of notifiable diseases. United States, 1993. MMWR. 1994;42:3
39. Wenger JD, Hightower AW, Facklam RR, et al. Bacterial meningitis in the United States, 1986: report of a multistate surveillance study. J Infect Dis. 1990;162:1316-1323
40. Feigin RD, McCracken GH Jr, Klein JO. Diagnosis and management of meningitis. Pediatr Infect Dis J. 1992;11:785-814
41. Bonadio WA. The cerebrospinal fluid: physiologic aspects and alterations associated with bacterial meningitis. Pediatr Infect Dis J. 1992;11: 423-432
42. Bonadio WA, Mannenbach M, Krippendorf R. Bacterial meningitis in older children. Am J Dis Child. 1990;144:463-465
43. Cabellos C, Martinez-Lacasa J, Martos A, et al. Influence of dexamethasone on efficacy of ceftriaxone and vancomycin therapy in experimental pneumococcal meningitis. Antimicrob Agents Chemother. 1995;39: 2158-2160
44. Schaad UB, Krucko J, Pfenninger J. An extended experience with cehiroxime therapy of childhood bacterial meningitis. Pediatr Infect Dis J. 1984;3:410-416
45. Blazer S, Berant M, Alon U. Bacterial meningitis: effect of antibiotic treatment on cerebrospinal fluid. Am J Clin Pathol. 1983;80:386-387
46. Roine I, Foncea LM, Ledermann W, Peltola H. Slow recovery of cerebrospinal fluid glucose and protein concentrations distinguish pneumococcal from Haemophilus influenzae and meningococcal meningitis in children. Pediatr Infect Dis J. 1995;14:905-907
47. Bohr V, Rasmussen N, Hansen B, et al. 875 cases of bacterial meningitis. II. Diagnostic procedures and the impact of preadmission antibiotic therapy. J Infect. 1983;7:193-202
48. Rorabaugh ML, Berlin LE, Heldrich F, et al. Aseptic meningitis in infants younger than 2 years of age: acute illness and neurologic complications. Pediatrics. 1993;92:206-211
49. Schaad UB, McCracken GH Jr, Loock CA, Thomas ML. Pharmacokinetics and bacteriological efficacy of moxalactam, cefotaxime, cefoperazone, and rocephin in experimental bacterial meningitis. J Infect Dis. 1981;143:156-163
50. Hieber JP, Nelson JD. A pharmacologic evaluation of penicillin in children with purulent meningitis. N Engl J Med. 1977;297:410-413
51. Kleiman MB, Weinberg GA, Reynolds JK, Allen SD. Meningitis with beta-lactam resistant Streptococcus pneumoniae: the need for early repeat lumbar puncture. Pediatr Infect Dis J. 1993;12:782-784
52. John CC. Treatment failure with use of a third-generation cephalosporin for penicillin-resistant pneumococcal meningitis: case report and review. Clin Infect Dis. 1994;18:188-193
53. Leggiadro RJ, Barrett FF, Chesney PJ, Davis Y, Tenover FC. Invasive pneumococci with high-level penicillin and cephalosporin resistance at a mid-south children's hospital. Pediatr Infect Dis J. 1994;13:320-323
54. Tan TQ, Schutze GE, Mason EO, Kaplan SL. Antibiotic therapy and acute outcome of meningitis due to Streptococcus pneumoniae considered intermediately susceptible to broad-spectrum cephalosporins. Antimicrob Agents Chemother. 1994;38:918-923
55. Yogev R, Shulman ST, Chadwick EG, David AT, Glogowski W. Once daily ceftriaxone for central nervous system infections and other serious pediatric infections. Pediatr Infect Dis J. 1986;5:298-303
56. Congeni BL, Bardley J, Hammerschlag MR. Safety and efficacy of once daily ceftriaxone for the treatment of bacterial meningitis. Pediatr Infect Dis J. 1986;5:293-297
57. Bradley JS, Kaplan SL, Klugman KP, Leggiadro RJ. Consensus: management of infections in children caused by Streptococcus pneumoniae with decreased susceptibility to penicillin. Pediatr Infect Dis J. 1995;14: 1037-1041
58. Viladrich PF, Cabellos C, Pallares R, et al. High doses of cefotaxime in treatment of adult meningitis due to Streptococcus pneumoniae with decreased susceptibilities to broad spectrum cephalosporins. Antimicrob Agents Chemother. 1996;40:218-220
59. Viladrich PF, Gudiol F, Linares J, et al. Evaluation of vancomycin for therapy in adult pneumococcal meningitis. Antimicrob Agents Chemother. 1991;35:2467-2472
60. Chesney PJ, Davis Y, English BK, Wang WC. Occurrence of Streptococcus pneumoniae meningitis during vancomycin and cefotaxime therapy of septicemia in a patient with sickle cell disease. Pediatr Infect Dis J. 1995;14:1013-1015
61. Friedland IR, Paris MM, Ehrett S, Hickey SM, Olsen KD, McCracken GH Jr. Evaluation of antimicrobial regimens for treatment of experimental penicillin and cephalosporin-resistant pneumococcal meningitis. Antimicrob Agents Chemother. 1993;37:1630-1636
62. Friedland IR, Paris MM, Shelton S, McCracken GH Jr. Time-kill studies of antibiotic combinations against penicillin-resistant and-susceptible Streptococcus pneumoniae. J Antimicrob Chemother. 1994;34:231-237
63. Munoz M, Valderrabanos ES, Diaz E, et al. Appearance of resistance to beta-lactam antibiotics during therapy for Streptococcus pneumoniae meningitis. J Pediatr. 1995;127:98-99
64. Boswell TC, Smith EG, Ayres JG. Problems in the management of penicillin-resistant pneumococci. J Hosp Infect. 1995;30:233-240
65. Paris MM, Hickey SM, Uscher MI, Shelton S, Olsen KD, McCracken GH Jr. Effect of dexamethasone on therapy of experimental penicillin-and cephalosporin-resistant pneumococcal meningitis. Antimicrob Agents Chemother. 1994;38:1320-1324
66. Tubau F, Cabellos C, Linares J. Lack of correlation between in vitro and in vivo studies of combinations of rifampin plus vancomycin or β-lactam antibiotics against Streptococcus pneumoniae. Antimicrob Agents Chemother. 1996;40:1573-1574
67. Friedland IR, Klugman KP. Failure of chloramphenicol therapy in penicillin resistant pneumococcal meningitis. Lancet. 1992;1:405-408
68. Wong VK, Wright HT, Ross LA, Mason WH, Inderlied CB, Sikkim K. Imipenem/cilastatin treatment of bacterial meningitis in children. Pediatr Infect Dis J. 1991;10:122-125
69. Klugman KP, Dagan R, The Meropenem Meningitis Study Group. Randomized comparison of meropenem with cefotaxime for treatment of bacterial meningitis. Antimicrob Agents Chemother. 1995;39:1140-1146
70. Committee on Infectious Diseases, American Academy of Pediatrics. Sect 5. Antimicrobials and related therapy. In: Peter G, ed. 1997 Red Book. Report of the Committee on Infections Diseases. 24th ed. Elk Grove Village, IL: American Academy of Pediatrics; 1997;000:000
71. Prober CG. The role of steroids in the management of children with bacterial meningitis. Pediatrics. 1995;95:29-31
72. Long SS. Dexamethasone for bacterial meningitis. Pediatrics. 1996;332: 893-894
73. Arditi M, The US Pediatric Multicenter Pneumococcal Surveillance Group (PMPSG). Clinical and microbiological characteristics of pneumococcal meningitis in children. In: Program and abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy (New Orleans, LA). Washington DC: American Society for Microbiology; 1996:251 #K10
74. Gaillard JL, Abadie V, Cheron G, et al. Concentrations of ceftriaxone in cerebrospinal fluid of children with meningitis receiving dexamethasone therapy. Antimicrob Agents Chemother. 1994;38:1209-1210
75. Latif R, Dajani AS. Ceftriaxone diffusion into cerebrospinal fluid of children with meningitis. Antimicrob Agents Chemother. 1983;23:46-48
76. Pallares R, Linares J, Vadillo M, et al. Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. N Engl J Med. 1995;333:474-480
77. Jackson MA, Shelton S, Nelson JD, McCracken GH Jr. Relatively penicillin-resistant pneumococcal infections in pediatric patients. Pediatr Infect Dis J. 1984;3:129-132
78. Willett LD, Dillon HC Jr, Gray BM. Penicillin-intermediate pneumococci in a children's hospital. Am J Dis Child. 1985;139:1054-1057
79. Chesney PJ, Wilimas JA, Presbury G, et al. Penicillin-and cephalosporin-resistant strains of Streptococcus pneumoniae causing sepsis and meningitis in children with sickle cell disease. J Pediatr. 1995;127:526-532
80. Simpson JM, Patel JS, Ispahani P. Streptococcus pneumoniae invasive disease in the neonatal period: an increasing problem? Eur J Pediatr. 1995;154:563-566
81. Pavis A, Cortey A, Lozniewski A, Wever M, Vert P. Early-onset septicemia in a newborn due to a penicillin resistant pneumococcus probably transmitted during delivery. Eur J Clin Microbiol Infect Dis. 1995;14: 68-69
82. Centers for Disease Control, Prevention and the Hospital Infection Control Practices Advisory Committee. Guideline for isolation precautions in hospitals. II. Recommendations for isolation precautions in hospitals. Am J Infect Control. 1996;24:32-52